Neurofibroma

Oncology·MeSH: Neurofibromatoses

8 drugs in development·4 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(4)

Drug	Company
Selumetinib	ASTRAZENECA PLC (AZN)
selumetinib capsule formulation	ASTRAZENECA PLC (AZN)
selumetinib granule formulation	ASTRAZENECA PLC (AZN)
tq-b3234	SPRING PHARMACEUTICAL GROUP, INC. (CYIG)

Phase 2(3)

Drug	Company
mirdametinib	SpringWorks Therapeutics, Inc. (SWTX)
mirdametinib	SpringWorks Therapeutics, Inc. (SWTX)
mirdametinib	SpringWorks Therapeutics, Inc. (SWTX)

Phase 2/Phase 3(1)

Drug	Company
REC-2282	RECURSION PHARMACEUTICALS, INC. (RXRX)

BioSniper tracks 8 drugs in development for Neurofibroma across 4 companies.

There are 1 clinical trial targeting Neurofibroma tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.